Cargando…

When human guanylate-binding proteins meet viral infections

Innate immunity is the first line of host defense against viral infection. After invading into the cells, pathogen-associated-molecular-patterns derived from viruses are recognized by pattern recognition receptors to activate the downstream signaling pathways to induce the production of type I inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rongzhao, Li, Zhixin, Tang, Yan-Dong, Su, Chenhe, Zheng, Chunfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934404/
https://www.ncbi.nlm.nih.gov/pubmed/33673837
http://dx.doi.org/10.1186/s12929-021-00716-8
_version_ 1783660808039825408
author Zhang, Rongzhao
Li, Zhixin
Tang, Yan-Dong
Su, Chenhe
Zheng, Chunfu
author_facet Zhang, Rongzhao
Li, Zhixin
Tang, Yan-Dong
Su, Chenhe
Zheng, Chunfu
author_sort Zhang, Rongzhao
collection PubMed
description Innate immunity is the first line of host defense against viral infection. After invading into the cells, pathogen-associated-molecular-patterns derived from viruses are recognized by pattern recognition receptors to activate the downstream signaling pathways to induce the production of type I interferons (IFN-I) and inflammatory cytokines, which play critical functions in the host antiviral innate immune responses. Guanylate-binding proteins (GBPs) are IFN-inducible antiviral effectors belonging to the guanosine triphosphatases family. In addition to exerting direct antiviral functions against certain viruses, a few GBPs also exhibit regulatory roles on the host antiviral innate immunity. However, our understanding of the underlying molecular mechanisms of GBPs' roles in viral infection and host antiviral innate immune signaling is still very limited. Therefore, here we present an updated overview of the functions of GBPs during viral infection and in antiviral innate immunity, and highlight discrepancies in reported findings and current challenges for future studies, which will advance our understanding of the functions of GBPs and provide a scientific and theoretical basis for the regulation of antiviral innate immunity.
format Online
Article
Text
id pubmed-7934404
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79344042021-03-08 When human guanylate-binding proteins meet viral infections Zhang, Rongzhao Li, Zhixin Tang, Yan-Dong Su, Chenhe Zheng, Chunfu J Biomed Sci Review Innate immunity is the first line of host defense against viral infection. After invading into the cells, pathogen-associated-molecular-patterns derived from viruses are recognized by pattern recognition receptors to activate the downstream signaling pathways to induce the production of type I interferons (IFN-I) and inflammatory cytokines, which play critical functions in the host antiviral innate immune responses. Guanylate-binding proteins (GBPs) are IFN-inducible antiviral effectors belonging to the guanosine triphosphatases family. In addition to exerting direct antiviral functions against certain viruses, a few GBPs also exhibit regulatory roles on the host antiviral innate immunity. However, our understanding of the underlying molecular mechanisms of GBPs' roles in viral infection and host antiviral innate immune signaling is still very limited. Therefore, here we present an updated overview of the functions of GBPs during viral infection and in antiviral innate immunity, and highlight discrepancies in reported findings and current challenges for future studies, which will advance our understanding of the functions of GBPs and provide a scientific and theoretical basis for the regulation of antiviral innate immunity. BioMed Central 2021-03-05 /pmc/articles/PMC7934404/ /pubmed/33673837 http://dx.doi.org/10.1186/s12929-021-00716-8 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Zhang, Rongzhao
Li, Zhixin
Tang, Yan-Dong
Su, Chenhe
Zheng, Chunfu
When human guanylate-binding proteins meet viral infections
title When human guanylate-binding proteins meet viral infections
title_full When human guanylate-binding proteins meet viral infections
title_fullStr When human guanylate-binding proteins meet viral infections
title_full_unstemmed When human guanylate-binding proteins meet viral infections
title_short When human guanylate-binding proteins meet viral infections
title_sort when human guanylate-binding proteins meet viral infections
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934404/
https://www.ncbi.nlm.nih.gov/pubmed/33673837
http://dx.doi.org/10.1186/s12929-021-00716-8
work_keys_str_mv AT zhangrongzhao whenhumanguanylatebindingproteinsmeetviralinfections
AT lizhixin whenhumanguanylatebindingproteinsmeetviralinfections
AT tangyandong whenhumanguanylatebindingproteinsmeetviralinfections
AT suchenhe whenhumanguanylatebindingproteinsmeetviralinfections
AT zhengchunfu whenhumanguanylatebindingproteinsmeetviralinfections